| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Eli Lilly and Company Common | Jul 1, 2026 | |
| Buy | Eli Lilly and Company Common | Jun 10, 2026 | |
| Sell | ELI LILLY & CO CMN | Jun 2, 2026 | |
| Buy | LILLY | Apr 30, 2026 | |
| Buy | ILLINOIS TOOL WORKS CMN | Apr 30, 2026 | |
| Buy | ELI LILLY AND COMPANY INC CM | Apr 29, 2026 | |
| Buy | LILLY | Apr 29, 2026 | |
| Buy | LILLY | Apr 24, 2026 | |
| Buy | LOWERS COMPANIES INC CMN | Apr 24, 2026 | |
| Buy | ELI LILLY AND CO INC CMN | Apr 24, 2026 |
This page tracks congressional stock trading activity in Eli Lilly and Company (LLY) in the company_delisted sector. Disclosed Capitol has indexed 337 disclosed congressional trades involving LLY. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of August 2026 — Disclosed Capitol has tracked 337 disclosed congressional trades in Eli Lilly and Company (LLY) — 147:85 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jul 1, 2026 | Michael Rulli | R | Sell | $1,001 - $15,000 |
| Jun 10, 2026 | Gilbert Cisneros | D | Buy | $50,001 - $100,000 |
| Jun 2, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Apr 30, 2026 | Michael McCaul | R | Buy | $100,001 - $250,000 |
| Apr 30, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 29, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 29, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 24, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Apr 24, 2026 | Ro Khanna | D | Buy | $15,001 - $50,000 |
| Apr 24, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
Across the 337 disclosed congressional trades in Eli Lilly and Company (LLY), members of Congress have reported 85 buys and 147 sells. The average 30-day alpha vs. the S&P 500 is 0.81%.
As of May 2026, Eli Lilly and Company has 14 federal contract award records on file from USAspending.gov — most recently $52K from the Department of Veterans Affairs on 2026-05-15.
| Award date | Agency | Amount |
|---|---|---|
| 2026-05-15 | Department of Veterans Affairs | $52K |
| 2025-10-06 | Department of Veterans Affairs | $230K |
| 2022-08-31 | Department of Defense · Department of the Army | $109.5M |
| 2022-06-28 | Department of Defense · Department of the Army | $273.8M |
| 2022-02-10 | Department of Defense · Department of the Army | $1.08B |
| 2021-11-01 | Department of Defense · Department of the Army | $1.29B |
| 2021-09-14 | Department of Defense · Department of the Army | $329.8M |
| 2021-04-07 | Department of Defense · Department of the Army | -$438.6M |
| 2021-02-25 | Department of Defense · Department of the Army | $210.0M |
| 2021-01-26 | Department of Defense · Department of the Army | $625.0M |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, Eli Lilly and Company reported revenue of $65.18B and net income of $20.64B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $22.97B, net income $7.09B.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.